This project will identify genetic factors that predict individual resilience to cognitive impairment arising from Alzheimer's disease (AD) or cerebrovascular disease. At autopsy, approximately 30% of cognitively normal individuals have the pathological features of AD or cerebrovascular disease. Yet, to date very little research has focused on the genetic factors that might contribute to such resilience. The objective of this application is to identify genetic variants that modify the association between AD pathology, cerebrovascular disease, and cognitive impairment. This work will leverage data from 6 datasets across the country to both discover and replicate such gene-environment interaction effects. In addition, it will look for interactions using both in vivo biomarker data and ex vivo autopsy data n order to provide a second level of validation. The main hypothesis is that genes within relevant molecular pathways identified in preliminary analyses (lipid transportation, genetic stability, and tau phosphorylation) will predict resilience to the pathologic cascade in dementia. Based on this hypothesis, the primary aims of this application will identify and replicate genetic variants that:1) confer resilience from tau- and amyloid- related cognitive decline; 2) modify relations between vascular risk, cerebrovascular disease, and cognitive decline; and 3) modify the relationship between AD and cerebrovascular pathologies. The complimentary training plan will equip the candidate with the skills necessary to build out an independent research career focused on genetic resilience by emphasizing the following training content areas: 1) autopsy methodology and advanced metrics of pathology; 2) AD biomarkers quantified in cerebrospinal fluid; 3) Neuroimaging of vascular disease; and 4) the clinical characterization of AD and vascular dementia. The mentor team is made up of experts in each of these content areas and will be combined with the interdisciplinary training program in the Vanderbilt Memory and Alzheimer's Center and the cutting edge computational and genomic resources available at Vanderbilt University Medical Center. Together, these practical and intellectual resources will provide the ideal training environment for the candidate. The primary mentor, Dr. Angela Jefferson, has a strong funding history and all the financial resources needed to support the candidate. These extensive resources will allow the candidate to dedicate 100% protected effort as an Assistant Professor to focus on research and career development. This will ensure that Dr. Hohman is fully prepared to compete for independent funding (R01) over the course of the proposed award period.

Public Health Relevance

A striking subset of cognitively normal individuals have brains with all the pathology of Alzheimer's and cerebrovascular disease. The goal of this project is to identify the genetic factors that help these 'asymptomatic' individuals ward off the damaging effects of dementia. Such genetic factors may provide targets for clinical intervention aimed at boosting natural defenses to neurodegenerative disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
6K01AG049164-02
Application #
9272983
Study Section
Neuroscience of Aging Review Committee (NIA)
Program Officer
Miller, Marilyn
Project Start
2016-05-03
Project End
2021-02-28
Budget Start
2016-05-03
Budget End
2017-02-28
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
079917897
City
Nashville
State
TN
Country
United States
Zip Code
37232
Jefferson, Angela L; Cambronero, Francis E; Liu, Dandan et al. (2018) Higher Aortic Stiffness Is Related to Lower Cerebral Blood Flow and Preserved Cerebrovascular Reactivity in Older Adults. Circulation 138:1951-1962
Gifford, Katherine A; Liu, Dandan; Neal, Jacquelyn E et al. (2018) Validity and Normative Data for the Biber Figure Learning Test: A Visual Supraspan Memory Measure. Assessment :1073191118773870
Emrani, Sheina; Libon, David J; Lamar, Melissa et al. (2018) Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall. J Alzheimers Dis 61:917-928
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998
Cambronero, Francis E; Liu, Dandan; Neal, Jacquelyn E et al. (2018) APOE genotype modifies the association between central arterial stiffening and cognition in older adults. Neurobiol Aging 67:120-127
Moore, Elizabeth E; Hohman, Timothy J; Badami, Faizan S et al. (2018) Neurofilament relates to white matter microstructure in older adults. Neurobiol Aging 70:233-241
Osborn, Katie E; Liu, Dandan; Samuels, Lauren R et al. (2018) Cerebrospinal fluid ?-amyloid42 and neurofilament light relate to white matter hyperintensities. Neurobiol Aging 68:18-25
Hohman, Timothy J; Dumitrescu, Logan; Cox, Nancy J et al. (2017) Genetic resilience to amyloid related cognitive decline. Brain Imaging Behav 11:401-409
Varma, V R; Varma, S; An, Y et al. (2017) Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry 22:13-23

Showing the most recent 10 out of 17 publications